The University of Montana logo WELCOME TO LISTSERV 15.0

Help for ORSP-BIOMED-L Archives


ORSP-BIOMED-L Archives

ORSP-BIOMED-L Archives


View:

Next Message | Previous Message
Next in Topic | Previous in Topic
Next by Same Author | Previous by Same Author
Chronologically | Most Recent First
Proportional Font | Monospaced Font

Options:

Join or Leave ORSP-BIOMED-L
Reply | Post New Message
Search Archives


Subject: DoD Prostate Cancer Pre-Announcement
From: "Fredenberg, Judy" <[log in to unmask]>
Reply-To:Research & Sponsored Programs <[log in to unmask]>
Date:Thu, 23 Dec 2010 08:27:24 -0700
Content-Type:text/plain
Parts/Attachments:
Parts/Attachments

text/plain (142 lines)


Please inform researchers interested in Prostate Cancer research funding
opportunities at University of Montana, the Congressionally Directed
Medical Research Programs (CDMRP) is announcing the Prostate Cancer
research funding mechanisms anticipated for Fiscal Year 20ll.  Please
consider sending this News Release on to your bio-life, clinical,
oncology, health disparity scientists from pre-doctoral to clinical
trial collaborations focused on Prostate Cancer research.

The news release below provides the information in a bullet format.  The
news release is located on the CDMRP website: 
http://cdmrp.army.mil/pubs/press/2010/11pcrppreann.shtml.  

Details of each award mechanism will be provided in the Program
Announcements when released. There is no information on dates, such as
when the Program Announcements will be released, when the deadlines
might occur, etc., at this time.  

Additional notifications will be sent when Program Announcements are
released. Requests for email notification of the Program Announcements
release may be sent to [log in to unmask] For more information about the
PCRP or other CDMRP-administered programs, please visit the CDMRP
website (http://cdmrp.army.mil). 
	
Department of Defense Prostate Cancer Research Program
Anticipated Funding Opportunities for Fiscal Year 2011 (FY11)

The Department of Defense Prostate Cancer Research Program (PCRP) is
administered by the US Army Medical Research and Materiel Command
(USAMRMC) through the Office of the Congressionally Directed Medical
Research Programs (CDMRP). 

Congressional funds for the FY11 PCRP have not yet been appropriated.
However, the PCRP is providing the information in this pre-announcement
to allow investigators time to plan and develop applications. The PCRP
anticipates offering the following award mechanisms for FY11 pending the
availability of congressional funds. This pre-announcement should not be
construed as an obligation by the government. 

IMPORTANT: The FY11 PCRP will use two Overarching Challenges and six
Focus Areas to direct/frame applications for funding: 
*Overarching Challenges: Development of effective treatments for
advanced prostate cancer, Distinguish aggressive from indolent disease  
*Focus Areas: Biomarkers, Genetics, Imaging, Survivorship, Therapy,
Tumor Biology and Immunology

1.  Clinical Trial Award
Supports rapid execution of early phase clinical trials that have the
potential for significant impact on prostate cancer 
Studies may include evaluation of novel drug , biologic, device,
surgical procedure, rehabilitative modality, behavioral or other
intervention 

2.  Exploration-Hypothesis Development Award

Supports highly innovative, untested, potentially groundbreaking
concepts in prostate cancer

3.  Health Disparity Research Award
Supports high-impact approaches to prostate cancer health disparity
research that represent new ideas and, if successful, will significantly
accelerate the elimination of death and suffering from prostate cancer 
New Investigator Option supports applicants early in their faculty
appointments or in the process of developing 
Qualified Collaborator Option (QCO) qualifies studies for higher level
of funding 

4.  Idea Development Award
Supports new ideas that represent innovative, high-risk/high-gain
approaches to prostate cancer research and, if successful, will
significantly accelerate the elimination of death and suffering from
prostate cancer 
New Investigator Option supports applicants early in their faculty
appointments or in the process of developing independent research
careers 

5.  Impact Award
Supports high-impact studies towards reducing or eliminating the problem
of overtreatment of primary prostate cancer 
Areas of special interest include but are not limited to active
surveillance, biomarkers, improved staging, local staging, and optimal
measures for follow-up and biopsy 

6.  Laboratory-Clinical Transition Award
Supports goal- and product-driven preclinical studies of promising lead
agents to IND and/or cGMP production that may revolutionize prostate
cancer clinical care 

7.  Population-Based Research Award
Supports high-impact approaches to prostate cancer research from the
perspective of population-based studies that will, if successful,
significantly accelerate the elimination of death and suffering from
prostate cancer 

8.  Synergistic Idea Development Award
Supports new or existing partnerships between two or three independent
investigators to address a central innovative question in prostate
cancer that may include high risk, provided there is a potential for
significant impact 

9.  Collaborative Undergraduate Historically Black Colleges and
Universities (HBCU) Student Summer Training Program Award

Supports new or existing summer prostate cancer training programs for
undergraduate HBCU students at host institutions

10.  Health Disparity Training  
Supports training in prostate cancer health disparity research for
individuals in the early stages of their careers 

11.  Physician Research Training Award
Supports training of physicians with clinical duties for careers in
prostate cancer research 

12.  Postdoctoral Fellowship Award
Supports prostate cancer research training for talented individuals in
the early stages of their careers 

The government reserves the right to make changes to the award
mechanisms offered and the mechanism elements if necessary. All
applications must conform to the final program announcements and
application instructions that will be available for electronic
downloading from the Grants.gov website. The application package
containing the required forms for each award mechanism will also be
found on Grants.gov. A listing of all USAMRMC funding opportunities can
be obtained on the Grants.gov website by performing a basic search using
CFDA Number 12.420. 

A pre-application is required for all award mechanisms and must be
submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to
application submission. Applications must be submitted through the
federal government's single-entry portal, Grants.gov. Requests for email
notification of the program announcements release may be sent to
[log in to unmask] For more information about the PCRP or other
CDMRP-administered programs, please visit the CDMRP website
(http://cdmrp.army.mil). 


Point of Contact: 
CDMRP Public Affairs
Jennie Mettert-Young
301-619-9783
[log in to unmask] 

Back to: Top of Message | Previous Page | Main ORSP-BIOMED-L Page

Permalink



LISTS.UMT.EDU

CataList Email List Search Powered by the LISTSERV Email List Manager